Synergistic action of the MCL-1 inhibitor S63845 with current therapies in preclinical models of triple-negative and HER2-amplified breast cancer
2017 · Science Translational Medicine · 191 citations
https://doi.org/10.1126/scitranslmed.aam7049
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
16
Papers
461
Citations
5
h-index
5
i10-index
Antonin Serrano is an academic researcher from The University of Melbourne. The author has contributed to research in topics: Cancer Cells and Metastasis & Cancer Genomics and Diagnostics & Single-cell and spatial transcriptomics. The author has an h-index of 5, co-authored 14 publications.
ORCID: 0000-0002-8178-6441https://doi.org/10.1126/scitranslmed.aam7049
https://doi.org/10.1038/s44320-026-00194-w
Click to start Chat